Waldenstrom's Macroglobulinemia Program Dana-Farber Cancer Institute
  Publications
  Media
 
 
  Email this page to a friend >

 

   
 

Below are all of the recent publications on Waldenstroms that our program has assisted in. Those interested in reading one of the full articles should consult a local medical library for back issues of the journal in which the article appeared or purchase a reprint online directly from the journal's web page.

Sort By:  

Show Publications By:


Resveratrol exerts antiproliferative effects and induces apoptosis in Waldenstrom’s Macroglobulinemia
3/15/2008
By AM Roccaro, X Leleu, AS Moreau, C Patterson, L Xu, A Jia, H N'Go, A Sacco, Y Cao, B Ciccarelli, R Manning, S Adamia, E Hatjiharissi, D Russo, A Vacca, F Dammacco, IM Ghobrial, SP Treon

Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
3/1/2008
By MN Menke, GT Feke, JW McMeel, SP Treon

CD27-CD70 interactions in the pathogenesis of Waldenstrom’s Macroglobulinemia
1/23/2008
By AW Ho, E Hatjiharissi, AR Branagan, ZR Hunter, X Leleu, O Tournilhac, L Xu, KE O'Connor, R Manning, DD Santos, MZ Chemaly, B Ciccarelli, C Patterson, J Soumerai, N Munshi, J McEarchern, C Law, IS Grewal , SP Treon

Increased natural killer cell expression of CD16 and augmented binding and ADCC activity to rituximab among individuals expressing the Fc gamma RIIIA-158 V/V and V/F polymorphism
10/1/2007
By E Hatjiharissi, L Xu, DD Santos, ZR Hunter, B Ciccarelli, S Verselis, M Modica, Y Cao, R Manning, X Leleu, EA Dimmock, A Kortsaris, C Mitsiades, KC Anderson, EA Fox, SP Treon

Genetic linkage of Fc gammaRIIa and Fc gammaRIIIa and implications for their use in predicting clinical responses to CD20 directed monoclonal antibody therapy
10/1/2007
By E Hatjiharissi, M Hansen, DD Santos, L Xu, X Leleu, EA Dimmock, A Ho, ZR Hunter, AR Branagan, C Patterson, A Kortsaris, S Verselis, EA Fox, SP Treon


View All Publications >>